PillNystatin And Triamcinolone Acetonide
Nystatin + Triamcinolone Acetonide
10 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it10 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | unknown | 6 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 4 | SUPPLYING |
| Torrent Pharmaceuticals Limited | unknown | 3 | SUPPLYING |
| Crown Laboratories | unknown | 3 | SUPPLYING |
| Macleods Pharmaceuticals Limited | unknown | 3 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | unknown | 3 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 3 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 2 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 17, 2019RECALLRecall (Class III): Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin Pharma…
Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation. — Recalling firm: Lupin Pharmaceuticals Inc. — Nationwide within the United States
- Mar 28, 2017RECALLRecall (Class II): Nystatin and Triamcinolone Acetonide Cream, USP, 100,000 USP nystatin units and 1 mg triamcinolone acetonide, distribut…
Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability — Recalling firm: Taro Pharmaceuticals U.S.A., Inc. — Nationwide and Puerto Rico